TYK Medicines non-executive director Jiang Mingyu resigns, Wu Yusheng named authorized representative
PUBT · 1d ago
Share
Listen to the news
- TYK Medicines announced the resignation of non-executive director Jiang Mingyu, effective Aug. 17, 2026.
- Wu Yusheng was appointed authorized representative from the same date; he founded the group in 2017 and serves as chairman, CEO.
- Directors set for re-election at an upcoming EGM include Wu as executive director, plus several non-executive and independent non-executive directors.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260817-12287353), on August 17, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending